{"id":"flutropium","rwe":[],"tags":[{"label":"flutropium","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"ba 598","offLabel":[],"synonyms":["flutropium bromide monohydrate","Ba 598 BR","Ba 598","Ba-598","flutropium bromide","flutropium"],"timeline":[],"approvals":[],"brandName":"Ba 598","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"flutropium","explanation":"Imagine your airways are like a narrow tube that can get constricted when you have a cold or asthma. Flutropium helps to relax the muscles around this tube, making it easier to breathe. This is similar to how other bronchodilators work, but the specific details of flutropium's mechanism are not well understood.","oneSentence":"Flutropium is a bronchodilator that works by relaxing the muscles in the airways to improve breathing.","technicalDetail":"Flutropium is a muscarinic receptor antagonist that acts on the M3 receptor subtype to inhibit acetylcholine-mediated bronchoconstriction."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/1228","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=FLUTROPIUM","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T11:34:34.099273","biosimilars":[],"competitors":[],"genericName":"flutropium","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NDDF":"008212","UNII":"TA73FX29II","CHEBI":"CHEBI:31630","INN_ID":"5406","UMLSCUI":"C0873172","ChEMBL_ID":"CHEMBL2110646","KEGG_DRUG":"D02417","PUBCHEM_CID":"656603","SECONDARY_CAS_RN":"754131-59-4","MESH_SUPPLEMENTAL_RECORD_UI":"C039778"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":12,"therapeuticAreas":["Respiratory"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Flutropium is a small molecule drug in the flutropium class, but specific details about its development, approval status, and indications are not available. As a result, there is limited information about its commercial status, safety considerations, and pharmacological properties. Further research is needed to understand the specifics of this compound. It is not clear what target it is designed to modulate or what diseases it is intended to treat. Overall, flutropium appears to be a relatively unknown compound.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}